AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Venous ThromboembolismThromboembolismPulmonary EmbolismVenous ThrombosisAnticoagulantsHeparin, Low-Molecular-WeightThrombophiliaThrombophlebitisWarfarinHemorrhageFibrin Fibrinogen Degradation ProductsEnoxaparinStockings, CompressionIschemiaFactor VVena Cava FiltersHeparinIntermittent Pneumatic Compression DevicesRecurrenceInternational Normalized RatioIncidenceFibrinolytic AgentsProthrombinVitamin KThrombosisActivated Protein C ResistanceContraceptives, Oral, CombinedConflict of InterestPostoperative ComplicationsDalteparinEmbolectomyRisk AssessmentAtrial FibrillationProspective StudiesProtein C DeficiencyTreatment OutcomeRetrospective StudiesPregnancy Complications, HematologicBandagesPhlebographyPostthrombotic SyndromeProtein S DeficiencyPregnancy Complications, CardiovascularFollow-Up StudiesBlood CoagulationAcenocoumarolNeoplasmsDesogestrelbeta-AlanineThiophenesAndrostenesTime FactorsPractice Guidelines as TopicFactor XaCohort StudiesContraceptives, OralLevonorgestrelRiskAdministration, OralGravity SuitsAustriaNorpregnenesContraceptives, Oral, SyntheticImmobilizationAntithrombin III DeficiencyInjections, SubcutaneousArthroplasty, Replacement, KneeAspirinAtrial AppendagePyridonesCase-Control StudiesCompression BandagesProtein CAcute DiseaseAerospace MedicineEchocardiography, TransesophagealVascular NeoplasmsThrombectomyHospitalizationAntithrombinsHeart Valve ProsthesisIntracranial Embolism and ThrombosisBlood Coagulation FactorsStrokePuerperal DisordersPartial Thromboplastin TimeRandomized Controlled Trials as TopicArthroplasty, Replacement, HipIntracranial ThrombosisAntiphospholipid SyndromeFemoral VeinBlood Coagulation TestsAge FactorsFactor VIIIPremedicationBlood Coagulation DisordersPlatelet Aggregation InhibitorsInpatientsAntithrombin IIIUnited States